Ocular Manifestations among COVID-19 Patients at the Field Hospital in Rayong Province

Main Article Content

Thanichaya Reanpinyawat

Abstract

BACKGROUND: The first case report of COVID-19 infection was accomplished in Rayong Province in December 2020, but the prevalence of ocular manifestations has not yet been reported


OBJECTIVES: To report the prevalence of ocular manifestations among COVID-19 patients at the field hospital in Rayong Province between 1 November 2021 to 31 January 2022.


METHODS: Electronic questionnaires filled out by patients and follow-up after 14 days of quarantine.


RESULTS: A total of 361 COVID-19 patients were included. Their age ranged from 18-68 years (mean age of 33.7 years). One hundred forty-two were male (39.3%) and two hundred nineteen were female (60.7%). There were 64 patients (17.8%) with underlying medical conditions, while ocular manifestations occurred in about 17.2%, which was due to conjunctivitis. The most common ocular symptoms included photophobia in 26 subjects (7.2%), tearing in 21 patients (5.8%), and red eye in 16 patients (4.4%).


CONCLUSIONS: Ocular manifestations can be found in approximately 17.2% of COVID-19 patients, and symptoms should be observed closely. Minimizing contact with tears is recommended to reduce transmission and, if ocular symptoms are observed, early detection should be initiated for early diagnosis and treatment.


Thaiclinicaltrials.org number, TCTR20220510008

Article Details

Section
Original Article

References

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579(7798):265-9.

Ali H, Hossain MF, Hasan MM, Abujar S. Covid-19 dataset: worldwide spread log including countries first case and first death. Data Brief [Internet]. 2020[cited 2021 Oct 30];32:106173. Available from: https://doi.org/10.1016/j.dib.2020.106173

Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32.

Aiello F, Afflitto GG, Mancino R, Li JO, Cesareo M, Giannini C. et al. Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review. Eye (Lond). 2020;34:1206-11.

Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020;138:575-8.

Ho D, Low R, Tong L, Gupta V, Veeraraghavan A, Agrawal R. COVID-19 and the ocular surface: a review of transmission and manifestations. Ocul Immunol Inflamm 2020;28:726-34.

Aggarwal K, Agarwal A, Jaiswal N, Dahiya N, Ahuja A, Mahajan S, et al. PLoS One [Internet]. 2020 [cited 2022 Feb 1];15(11):e0241661. Available from: https://doi.org/10.1371/journal.pone.0241661

Chen L, Deng C, Chen X, Zhang X, Chen B, Yu H, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol 2020;98:951-9.

Nasiri N, Sharifi H, Bazrafshan A, Noori A, Karamouzian M, Sharifi A. Ocular manifestations of COVID-19: a systematic review and meta-analysis. J Ophthalmic Vis Res 2021;16:103-12.

Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 and Eye: a review of ophthalmic manifestations of COVID-19. Indian J Ophthalmol 2021;69:488-509.

Douglas KAA, Douglas VP, Moschos MM. Ocular manifestations of COVID-19 (SARS-CoV-2): a critical review of current literature. In Vivo 2020;34(3 Suppl):1619-28.

Güemes-Villahoz N, Burgos-Blasco B, García-Feijoó J, Sáenz-Francés F, Arriola-Villalobos P, Martinez-de-la-Casa JM, et al. Conjunctivitis in COVID-19 patients: frequency and clinical presentation. Graefes Arch Clin Exp Ophthalmol 2020;258:2501-7.

Anka AU, Tahir MI, Abubakar SD, Alsabbagh M, Zian Z, Hamedifar H, et al. Coronavirus disease 2019 (COVID-19): an overview of the immunopathology, serological diagnosis and management. Scand J Immunol [Internet]. 2021 [cited 2022 Mar 15];93(4):e12998. Available from: https://doi.org/10.1111/sji.12998